Shoulder Innovations vs TriSalus Life Sciences
SI and TLSI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SI and TLSI compare
Shoulder Innovations is the larger company, worth 3.0 times as much as TriSalus Life Sciences ($426M against $140M).
Shoulder Innovations grew revenue faster over the last twelve months (60.9% versus 25.2% for TriSalus Life Sciences).
Shoulder Innovations keeps more of each dollar of sales as profit, with a net margin of −58.3% compared with −62.6% at TriSalus Life Sciences.
Shoulder Innovations scores higher on the StockData Score (7 against 5 for TriSalus Life Sciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SI | TLSI |
|---|---|---|
| Size and price | ||
| Market cap | $426M | $140M |
| Share price | $20.45 | $2.27 |
| Change, 1 year | 39.1% | −48.3% |
| Change, 5 years | – | −77.2% |
| Beta (5Y) | −0.51 | 2.31 |
| Employees | 75 | 102 |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 0 | 0 |
| Growth score | 3 | 3 |
| Performance score | 0 | 1 (better) |
| Health score | 4 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 7.1× | 3.1× (better) |
| P/B | 3.4× (better) | 21.3× |
| FCF yield | −11.1% (better) | −16.7% |
| Fair value | $13.52 | – |
| Margin of safety | −51.3% | – |
| Growth | ||
| Revenue growth (TTM) | 60.9% (better) | 25.2% |
| Profitability | ||
| Gross margin | 77.3% | 85.8% (better) |
| Operating margin | −58.5% (better) | −67.7% |
| Net margin | −58.3% (better) | −62.6% |
| FCF margin | −78.4% | −51.6% (better) |
| Return on equity | −152% | – |
| Financial health | ||
| Debt / equity | 0.12 (better) | 5.05 |
| Interest coverage | – | −5.2× |
| Current ratio | 10.71 (better) | 5.35 |
| Altman Z-score | 8.78 (better) | −6.04 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Buyback yield | – | −31.6% |
| Shareholder yield | 0.00% (better) | −31.6% |
| Ownership | ||
| Held by institutions | 39.8% | 38.6% |
| Held by insiders | 40.0% | 29.7% |
| Insider net buying, 12 months | −$5.3M | $3.5M (better) |
| Short interest, % of float | 5.7% | – |
Go deeper
- SI stock overview
- SI income statement
- SI valuation and score
- TLSI stock overview
- TLSI income statement
- TLSI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.